Neoadjuvant chemotherapy plus pembrolizumab vs chemotherapy alone for patients with early and advanced triple-negative breast cancer (TNBC): Outcomes from Berkshire Cancer Centre

Clinical Oncology 2026

View at publisher

Authors: Ismini Tsagkaraki, Anil Babar, Madhumita Bhattacharyya

DOI: 10.1016/j.clon.2025.104026

Cited by: 0

Fields of Study & Subjects

Breast Cancer Treatment Studies MRI in cancer diagnosis Breast Lesions and Carcinomas